You've done the injections. You've white-knuckled through the nausea. You've watched the scale move, slower than your friend's, or slower than the influencer whose before-and-afters got you interested in GLP-1s in the first place. Here's the plot twist nobody's telling you at the pharmacy counter: if you're perimenopausal or postmenopausal and not on hormone therapy, your GLP-1 might genuinely be working against a headwind your younger self never had to fight.

Key Takeaways

• Women taking a GLP-1 alongside hormone replacement therapy lose significantly more weight than women on a GLP-1 alone. One 2026 study found roughly 35% more weight loss with the combination.
• GLP-1 use is highest among women ages 50 to 64, with about one in five women in that age group having used one.
• Estrogen appears to enhance how GLP-1s suppress appetite, which may explain part of the gap. That's a biological mechanism, not a coincidence.
• Rapid weight loss on a GLP-1 can accelerate bone loss, and menopause is already doing that to you. Resistance training isn't optional here.
• A GLP-1 alone is treating the appetite. It's not touching the hormonal reason your body started hoarding belly fat in the first place.

Why Doesn't My GLP-1 Work As Well As It Used To?

Because your body isn't the same body the drug was studied on.

Most of the original GLP-1 trials were run on younger, still-cycling populations. Nobody bothered to ask what happens when you layer a GLP-1 on top of a body whose estrogen just packed its bags. Estrogen isn't just about hot flashes and mood swings, it's a metabolic hormone. It helps regulate where you store fat, how sensitive your cells are to insulin, and even how your brain interprets fullness signals. Pull estrogen out of the equation and you're not just losing a hormone, you're losing a metabolic teammate.

That's not a guess. A landmark study out of Mayo Clinic, published in The Lancet Obstetrics, Gynaecology & Women's Health in January 2026, tracked 120 postmenopausal women on tirzepatide for a year or more. The women also taking hormone therapy lost roughly 35% more weight than the ones on tirzepatide alone. A separate 2024 study in the journal Menopause found a similar pattern with semaglutide: 16% weight loss with hormone therapy added, versus 12% without it.

Preclinical research suggests part of the reason is that estrogen actually amplifies the appetite-suppressing effect of GLP-1s. Think of it like this: the GLP-1 is turning down the volume on your hunger signal, and estrogen is the amplifier that makes that turn-down actually audible. Without it, you're straining to hear a whisper.

Is It Safe to Combine a GLP-1 With HRT?

For most women without contraindications, yes, and the research suggests it's not just safe, it's smarter.

This isn't about stacking medications for the sake of it. It's about treating the actual system instead of one symptom of it. Your weight gain in midlife was never purely a calorie math problem. It's estrogen decline changing where fat gets stored (hello, new visceral belly fat that never used to live there), it's insulin sensitivity dropping, it's sleep falling apart so your hunger hormones get confused. A GLP-1 mutes the appetite. HRT addresses the hormonal shift driving the metabolic slowdown underneath it. Together they're doing two different jobs instead of one drug doing all the work solo.

That said, "safe for most women" isn't "safe for every woman," and any responsible provider will screen for hormone-sensitive cancers, uncontrolled cardiovascular disease, and clotting risk before combining anything.

The Bone Loss Warning Nobody's Talking About

Here's the part of the GLP-1 conversation that's getting dangerously quiet: weight loss is bone loss, and you're already losing bone.

Researchers, including bone health expert Wendy Kohrt, have flagged that GLP-1 use is climbing fastest among perimenopausal and early menopausal women, right as declining estrogen is already accelerating bone density loss on its own. Stack rapid weight loss on top of that, especially if some of what you're losing is muscle, and you've got two forces working against your skeleton at once. Strong muscle helps maintain bone density. Lose the muscle along with the fat and you've solved one problem while quietly creating another.

This is not a reason to avoid GLP-1s. It's a reason to stop treating them like a magic pill you can take with zero support around it. Resistance training two to three times a week, and enough protein to actually preserve muscle, aren't nice-to-haves in midlife. They're the non-negotiable insurance policy.

GLP-1 Alone vs. GLP-1 + HRT: What Actually Changes

Who This Combined Approach Is Built For (And Who Should Pause)

This is for women in perimenopause or menopause who've tried a GLP-1 and felt like it undersold on the promise, women who are dealing with weight gain and hot flashes and sleep issues and brain fog and are tired of being handed one prescription for one symptom at a time, and women who want a provider who's actually thinking about their bones and muscle, not just the number on the scale.

It's not the right starting point if you're looking for a fast fix with no monitoring. And it's a hard stop, not a soft suggestion, if you have a history of hormone-sensitive cancer, active cardiovascular disease, or clotting disorders. Those need specialist clearance before anything hormonal gets added to the mix.

FAQ

Does hormone therapy make GLP-1s work better?
Research suggests yes, women on both together tend to lose meaningfully more weight than those on a GLP-1 alone, likely because estrogen enhances the drug's effect on appetite regulation.

Will a GLP-1 make my menopause symptoms worse?
A GLP-1 doesn't target menopause symptoms directly, it's not designed to. If you're relying on it alone while hot flashes, sleep problems, or mood swings go untreated, you're still missing the hormonal piece.

Do GLP-1s cause bone loss in menopause?
Weight loss in general can accelerate bone loss, and that risk is higher in menopause when estrogen decline is already affecting bone density. Resistance training and adequate protein intake are essential alongside any GLP-1 use.

Can I combine a GLP-1 with hormone replacement therapy?
For most women without hormone-sensitive cancer, active cardiovascular disease, or clotting disorders, yes, and current research suggests the combination outperforms either treatment alone.

Why am I not losing weight as fast on a GLP-1 as I expected?
If you're perimenopausal or postmenopausal, declining estrogen may be working against the drug's effectiveness. It's not a willpower problem or a dosing failure, it's a missing hormonal piece.

The Bottom Line

A GLP-1 by itself is treating a symptom. Pairing it with hormone therapy treats the system that created the symptom in the first place. If you've been white-knuckling your way through a GLP-1 and wondering why it's not doing what it did for someone else, this might be why.

That's exactly why we built the Women's Peptide Weight Loss Program the way we did. Unlike a generic telehealth GLP-1 shop that just checks your weight and mails you a pen, we're managing this alongside your actual hormone picture, because your GI sensitivity, your bone density, and your dosing needs at 52 aren't the same as a 30-year-old's. And you're not locked into one path. Depending on what your labs and symptoms show, you can start with GLP-1s alone through the peptide program, or combine it with hormone therapy through the Midlife RESET if the data says your estrogen is part of what's standing in the way. Either way, it's built around what your body's actually doing, not a one-size prescription.

About the Author

Karen Martel is a Certified Hormone Specialist and Transformational Nutrition Coach who founded Karen Martel Midlife Solutions to address the gap in personalized women's hormonal healthcare. She specializes in bioidentical HRT, comprehensive hormone testing, and clinical coaching for women in perimenopause and menopause.